[18F]RM-365

N/A

Report date: 2023/10/16 16:31:27

Base Information

Drug Name[18F]RM-365
Drug Alias Name[18F]RM-365[18F]RM365
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products
Mechanisms of ActionCannabinoid CB2 receptor modulators
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz-Zentrum Dresden-Rossendorf
China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz-Zentrum Dresden-Rossendorf
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A